Literature DB >> 33633231

Comparison of the onset time between 0.375% ropivacaine and 0.25% levobupivacaine for ultrasound-guided infraclavicular brachial plexus block: a randomized-controlled trial.

Ha-Jung Kim1, Sooho Lee2, Ki Jinn Chin3, Jin-Sun Kim1, Hyungtae Kim1, Young-Jin Ro1, Won Uk Koh4.   

Abstract

At centers with pressure on rapid operating room turnover, onset time is one of the important considerations for choosing a local anesthetic drug. To hasten the onset of the block, higher concentrations of local anesthetics are sometimes used. However, the use of diluted local anesthetics may be safer. Therefore, we aimed to compare the onset times of equipotential levobupivacaine and ropivacaine at low concentrations for infraclavicular brachial plexus block. Adult patients undergoing upper extremity surgery under ultrasound-guided infraclavicular brachial plexus block at our center were randomly allocated to the levobupivacaine and ropivacaine groups. Infraclavicular brachial plexus block was induced with 0.25% levobupivacaine or 0.375% ropivacaine depending on the assigned group. The degrees of sensory and motor blockade were assessed for 40 min after the administration of local anesthetics. A total of 46 patients were included in the analysis. Infraclavicular brachial plexus block with 0.25% levobupivacaine and 0.375% ropivacaine provided sufficient surgical anesthesia. The sensory onset time of 0.375% ropivacaine was shorter than that of 0.25% levobupivacaine (group R, 15 [15.0-22.5] min; group L, 30 [17.5-35.0] min, p = 0.001). There were no significant differences in other block characteristics and clinical outcomes between the two groups. Thus, when a quicker block onset is required, 0.375% ropivacaine is a better choice than 0.25% levobupivacaine.Trial registration ClinicalTrials.gov (NCT03679897).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33633231      PMCID: PMC7907375          DOI: 10.1038/s41598-021-84172-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

1.  Ultrasound-guided infraclavicular brachial plexus block: an alternative technique to anatomical landmark-guided approaches.

Authors:  C Ootaki; H Hayashi; M Amano
Journal:  Reg Anesth Pain Med       Date:  2000 Nov-Dec       Impact factor: 6.288

2.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.

Authors:  John T Farrar; James P Young; Linda LaMoreaux; John L Werth; Michael R Poole
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

3.  Local anesthetic Schwann cell toxicity is time and concentration dependent.

Authors:  Sufang Yang; Matthew S Abrahams; Patricia D Hurn; Marjorie R Grafe; Jeffrey R Kirsch
Journal:  Reg Anesth Pain Med       Date:  2011 Sep-Oct       Impact factor: 6.288

4.  Comparison of 0.5% ropivacaine and 0.5% levobupivacaine for infraclavicular brachial plexus block.

Authors:  R Mageswaran; Y C Choy
Journal:  Med J Malaysia       Date:  2010-12

Review 5.  Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine.

Authors:  Stefania Leone; Simone Di Cianni; Andrea Casati; Guido Fanelli
Journal:  Acta Biomed       Date:  2008-08

6.  Increased success rate with infraclavicular brachial plexus block using a dual-injection technique.

Authors:  J Rodríguez; M Bárcena; J Lagunilla; J Alvarez
Journal:  J Clin Anesth       Date:  2004-06       Impact factor: 9.452

7.  Do the Concentration and Volume of Local Anesthetics Affect the Onset and Success of Infraclavicular Anesthesia?

Authors:  Faramarz Mosaffa; Babak Gharaei; Mohammad Qoreishi; Sajjad Razavi; Farhad Safari; Mohammad Fathi; Gholamreza Mohseni; Hedayatollah Elyasi; Fahimeh Hosseini
Journal:  Anesth Pain Med       Date:  2015-08-22

8.  A randomised comparative evaluation of supraclavicular and infraclavicular approaches to brachial plexus block for upper limb surgeries using both ultrasound and nerve stimulator.

Authors:  Ranganathan Jothi Abhinaya; Rajagopalan Venkatraman; Palanisamy Matheswaran; Govindarajan Sivarajan
Journal:  Indian J Anaesth       Date:  2017-07

9.  Ropivacaine versus levobupivacaine in peripheral nerve block: A PRISMA-compliant meta-analysis of randomized controlled trials.

Authors:  Ang Li; Zhijian Wei; Yang Liu; Jiaxiao Shi; Han Ding; Haoshuai Tang; Pengyuan Zheng; Yanzheng Gao; Shiqing Feng
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  Comparative evaluation of two approaches of infraclavicular brachial plexus block for upper-limb surgeries.

Authors:  Chandni Sinha; Neeraj Kumar; Amarjeet Kumar; Ajeet Kumar; Anup Kumar
Journal:  Saudi J Anaesth       Date:  2019 Jan-Mar
View more
  1 in total

1.  Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.

Authors:  Runze Zhang; Yanhong Lian; Kangjie Xie; Yunfang Cai; Yafei Pan; Yuntian Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.